David Lock is a successful business leader with a strong track record in the pharmaceutical and healthcare sector. Currently serving as the Head of Immunology for UCB in the UK and Ireland, David has transformed the immunology franchise into a multi-product powerhouse with several major biologics launches slated between 2021 and 2024. They held previous positions such as Regional Business Manager at Aventis and Director of Global Marketing Immunology at UCB Pharma, demonstrating extensive leadership of high-performing teams and expertise in biologic therapies. David continues to pursue a Bachelor of Science degree in Chemistry at Loughborough University.
This person is not in any teams
This person is not in any offices